Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 776-792

  Moriya, Kyoji ^a   Miyoshi, Hideyuki ^a   Shinzawa, Seiko ^a   Tsutsumi, Takeya ^a   Fujie, Hajime ^a   Goto, Koji ^a   Shintani, Yoshizumi ^a   Yotsuyanagi, Hiroshi ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antioxidant; Heme oxygenase 1; Hepatocellular carcinoma; Oxidative stress; Transgenic mouse

Indexed keywords

ANTIOXIDANT; COMPLEMENTARY DNA; CORE PROTEIN; FERROUS SULFATE; HEME OXYGENASE 1; IRON; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RNA; TRANSCRIPTION FACTOR NRF2; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IRON OVERLOAD; LIVER; LIVER CANCER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW; TRANSGENIC MOUSE; VIRUS CORE; WESTERN BLOTTING;

HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

EID: 77950991692     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21661     Document Type: Article

References (26)

1. Abdalla MY, Britigan BE, Wen F, Icardi M, McCormick ML, LaBrecque DR, Voigt M, Brown KE, Schmidt WN. 2004. Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein. J Infect Dis 190:1109-1118. (Pubitemid 39186798)
2. Chapoutot C, Esslimani M, Chapoutot C, Esslimani M, Joomaye Z, Ramos J, Perney P, Laurent C, Fabbro-Peray P, Larrey D, Domergue J, Blanc F. 2000. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 46:711-714. (Pubitemid 30305791)
3. Choi J, Ou JH. 2006.Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290:G847-G851.
4. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R. 1995. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449-456.
5. Farombi EO, Surh YJ. 2006. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 39:479-491. (Pubitemid 44714527)
6. Ferrándiz ML, Devesa I. 2008. Inducers of heme oxygenase-1. Curr Pharm Des 14:473-486.
7. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, Kobayashi Y, Iwasa M, Watanabe S, Adachi Y, Kaito M. 2007. Hepcidin expression in the liver: Relatively low level in patients with chronic hepatitis C. Mol Med 13:97-104.
8. Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, Kawanishi S, Watanabe S, Kaito M, Takei Y. 2008. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat 15:498-507. (Pubitemid 351798987)
9. Ghaziani T, Shan Y, Lambrecht RW, Donohue SE, Pietschmann T, Bartenschlager R, Bonkovsky HL. 2006. HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. J Hepatol 45:5-12. (Pubitemid 43850616)
10. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y. 2001. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 61:8697-8702.
11. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. 2006. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 80:7199-7207. (Pubitemid 44025216)
12. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-1067. (Pubitemid 28417341)
13. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Miyamura T, Kimura S, Koike K. 2001. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61:4365-4370.
14. Muckenthaler MU. 2008. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 8:1-3.
15. Naas T, Ghorbani M, Alvarez-Maya I, Lapner M, Kothary R, De Repentigny Y, Gomes S, Babiuk L, Giulivi A, Soare C, Azizi A, Diaz-Mitoma F. 2005. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. J Gen Virol 86:2185-2196.
16. Nioi P, Hayes JD. 2004. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 555:149-171.
17. Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, Furutani T, Sakai A, Okuda M, Hidaka I, Okita K, Sakaida I. 2008. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 134:226-238.
18. Oguro T, Hayashi M, Nakajo S, Numazawa S, Yoshida T. 1998. The expression of heme oxygenase-1 gene responded to oxidative stress produced by phorone, a glutathione depletor, in the rat liver; the relevance to activation of c-jun n-terminal kinase. J Pharmacol Exp Ther 287:773-778. (Pubitemid 29133682)
19. Ruggieri A, Murdolo M, Harada T, Miyamura T, Rapicetta M. 2004. Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing hepatitis C virus core protein. Arch Virol 149:61-74. (Pubitemid 38162100)
20. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q, Houghton M, Kuo G. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547-6549.
21. Shan Y, Lambrecht RW, Ghaziani T, Donohue SE, Bonkovsky HL. 2004. Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: Insights from studies with small interfering RNAS. J Biol Chem 279:51769-51774. (Pubitemid 39656543)
22. Srisook K, Kim C, Cha YN. 2005. Molecular mechanisms involved in enhancing HO-1 expression: De-repression by heme and activation by Nrf2, the "one-two" punch. Antioxid Redox Signal 7:1674-1687.
23. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-1046. (Pubitemid 17049750)
24. Tsutsumi T, Suzuki T, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Matsuura Y, Kimura S, Koike K, Miyamura T. 2002. Intrahepatic cytokine expression and AP-1 activation in mice transgenic for hepatitis C virus core protein. Virology 304:415-424.
25. Zhu L, Miller DD. 2007. Tissue iron distribution and urinary mineral excretion vary depending on the form of iron (FeSO4 or NaFeEDTA) and the route of administration in rats given high doses of iron. J Agric Food Chem 55:8793-8799. (Pubitemid 350013129)
26. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN. 2008. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 48:1430-1439.